Zobrazeno 1 - 10
of 513
pro vyhledávání: '"Arthur Kavanaugh"'
Autor:
Philip J. Mease, Alexis Ogdie, John Tesser, Natalie J. Shiff, Ruizhi Sophia Zhao, Soumya D. Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R. McLean, Aaron Broadwell, Arthur Kavanaugh, Joseph F. Merola
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 5, Pp 304-311 (2024)
Objective Evaluate patient‐reported outcomes after 6 months of on‐label guselkumab use in patients with rheumatologist‐diagnosed active psoriatic arthritis (PsA) enrolled in the CorEvitas PsA/Spondyloarthritis Registry. Methods This analysis in
Externí odkaz:
https://doaj.org/article/197c05cdb19f4b9fb26fe2baaf5f58b3
Autor:
Bruno Fautrel, Peter Nash, Arthur Kavanaugh, Peter C Taylor, René Westhovens, Rieke Alten, Janet Pope, Dick de Vries, Chris Watson, Georg Pongratz, Pieter-Jan Stiers, Ken Hasegawa, Shangbang Rao
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Objective This post hoc analysis of the FINCH 1–3 (NCT02889796, NCT02873936 and NCT02886728) studies assessed specific effects of filgotinib on pain control and their relationship with other aspects of efficacy in patients with rheumatoid arthritis
Externí odkaz:
https://doaj.org/article/1d73e4d9b70646f5a6466193ed608507
Autor:
Ruth Stoklund Thomsen, Tom Ivar Lund Nilsen, Glenn Haugeberg, Beathe Sitter, Arthur Kavanaugh, Susanne Juhl Pedersen, Mari Hoff
Publikováno v:
BMC Musculoskeletal Disorders, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background In psoriatic arthritis (PsA) there is a theoretical risk of increased disease activity related to strenuous physical activity, including exercise. We evaluated the effect of high intensity interval training (HIIT) on objective mea
Externí odkaz:
https://doaj.org/article/db7b631ae5914c87b204efde1102a53b
Autor:
Philip J. Mease, Alexis Ogdie, John Tesser, Natalie J. Shiff, Iris Lin, Soumya D. Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R. McLean, Aaron Broadwell, Arthur Kavanaugh, Joseph F. Merola
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1479-1501 (2023)
Abstract Introduction The aim of this work is to evaluate treatment persistence and clinical outcomes after 6 months of on-label guselkumab use in patients with rheumatologist-diagnosed active psoriatic arthritis (PsA) enrolled in the CorEvitas PsA/S
Externí odkaz:
https://doaj.org/article/670a15e0810945e28ecb889c8800099e
Autor:
Dafna D. Gladman, Philip J. Mease, Paul Bird, Enrique R. Soriano, Soumya D. Chakravarty, May Shawi, Stephen Xu, Sean T. Quinn, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai-Shan Tam, Philip S. Helliwell, Arthur Kavanaugh, Atul Deodhar, Mikkel Østergaard, Xenofon Baraliakos
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-14 (2022)
Abstract Background Axial involvement constitutes a specific domain of psoriatic arthritis (PsA). Interleukin (IL)-23 inhibitors have demonstrated improvement in axial PsA (axPsA) symptoms, but have not shown efficacy in treating ankylosing spondylit
Externí odkaz:
https://doaj.org/article/29c38a70b6d44575928210e60788a3e0
Autor:
Philip J. Mease, Soumya D. Chakravarty, Robert R. McLean, Taylor Blachley, Toana Kawashima, Iris Lin, Arthur Kavanaugh, Alexis Ogdie
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 5, Pp 447-456 (2022)
Objective Axial disease is common and burdensome in patients with psoriatic arthritis (PsA). Human leukocyte antigen‐B27 (HLA‐B27) is a risk factor for axial PsA; treatment response by HLA‐B27 status is inadequately characterized. This study ev
Externí odkaz:
https://doaj.org/article/828b574da8324b629792166478cec593
Autor:
M. Elaine Husni, Atul Deodhar, Sergio Schwartzman, Soumya D. Chakravarty, Elizabeth C. Hsia, Jocelyn H. Leu, Yiying Zhou, Kim H. Lo, Arthur Kavanaugh
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-13 (2022)
Abstract Background Intravenous (IV) golimumab, a TNFi, is approved for treating rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). We analyzed pooled safety results from three phase 3 IV golimumab trials in these
Externí odkaz:
https://doaj.org/article/09e6a686072943d2b8e0568dc745d31c
Autor:
Proton Rahman, Philip J. Mease, Philip S. Helliwell, Atul Deodhar, Laure Gossec, Arthur Kavanaugh, Alexa P. Kollmeier, Elizabeth C. Hsia, Bei Zhou, Xiwu Lin, May Shawi, Chetan S. Karyekar, Chenglong Han
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Abstract Background The interleukin-23p19-subunit inhibitor guselkumab effectively treats signs and symptoms of psoriatic arthritis (PsA). We evaluated the effect of guselkumab on fatigue. Methods Across two phase 3 trials of guselkumab (DISCOVER-1,
Externí odkaz:
https://doaj.org/article/f2f76733abb34796af8da2a53d489603
Autor:
Roxana Coras, Arthur Kavanaugh, Angela Kluzniak, Dustina Holt, Amy Weilgosz, Armando Aaron, Oswald Quehenberger, Christopher Ritchlin, Monica Guma
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-13 (2021)
Abstract Background Oxylipins are biological lipids that have been implicated in inflammation. We previously found that certain oxylipins correlated with clinical manifestations in psoriatic arthritis (PsA) patients. Here, we compare oxylipin profile
Externí odkaz:
https://doaj.org/article/070e850d2dcc42cd8ed7ed2d8b367286
Autor:
Atul Deodhar, Arthur Kavanaugh, Dafna D Gladman, Laura C Coates, Vibeke Strand, Philip S Helliwell, Alexis Ogdie, Lyrica X H Liu, Gregory Kricorian, David Collier, Phillip J Mease
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective We used the Study of Etanercept And Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA) data set to examine the impact of presence of enthesitis, dactylitis, nail disease and/or psoriasis on treatme
Externí odkaz:
https://doaj.org/article/d27b191a16d84799a9c5014934b2f0a7